140 related articles for article (PubMed ID: 6610485)
1. The mechanism of inhibition and "reversal" of mitogen-induced lymphocyte activation in a model of adenosine deaminase deficiency.
Albert D; Bluestein HG; Thompson L; Seegmiller JE
Cell Immunol; 1984 Jul; 86(2):510-7. PubMed ID: 6610485
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminase.
Lee N; Russell N; Ganeshaguru K; Jackson BF; Piga A; Prentice HG; Foa R; Hoffbrand AV
Br J Haematol; 1984 Jan; 56(1):107-19. PubMed ID: 6231047
[TBL] [Abstract][Full Text] [Related]
3. Differential inhibition of adenosine deaminase deficient peripheral blood lymphocytes and lymphoid line cells by deoxyadenosine and adenosine.
Hirschhorn R; Bajaj S; Borkowsky W; Kowalski A; Hong R; Rubinstein A; Papageorgiou P
Cell Immunol; 1979 Feb; 42(2):418-23. PubMed ID: 311698
[No Abstract] [Full Text] [Related]
4. A role for purine metabolism in the immune response: Adenosine-deaminase activity and deoxyadenosine catabolism.
Simmonds HA; Panayi GS; Corrigall V
Lancet; 1978 Jan; 1(8055):60-3. PubMed ID: 74565
[TBL] [Abstract][Full Text] [Related]
5. Altered deoxynucleoside triphosphate levels paralleling deoxyadenosine toxicity in adenosine deaminase inhibited human lymphocytes.
Bluestein HG; Thompson LF; Albert DA; Seegmiller JE
Adv Exp Med Biol; 1980; 122A():427-31. PubMed ID: 6968502
[No Abstract] [Full Text] [Related]
6. Accumulation of deoxyribonucleotides as a possible mediator of immunosuppression in hereditary deficiency of adenosine deaminase.
Bluestein HG; Willis RC; Thompson LF; Matsumoto S; Seegmiller JE
Trans Assoc Am Physicians; 1978; 91():394-402. PubMed ID: 314193
[No Abstract] [Full Text] [Related]
7. Rejection of bone marrow transplant and resistance of alloantigen reactive cells to in vivo deoxyadenosine in adenosine deaminase deficiency.
Cowan MJ; Shannon KM; Wara DW; Ammann AJ
Clin Immunol Immunopathol; 1988 Nov; 49(2):242-50. PubMed ID: 2971490
[TBL] [Abstract][Full Text] [Related]
8. Human B lymphocytes and thymocytes but not peripheral blood mononuclear cells accumulate high dATP levels in conditions simulating ADA deficiency.
Goday A; Simmonds HA; Morris GS; Fairbanks LD
Biochem Pharmacol; 1985 Oct; 34(19):3561-9. PubMed ID: 3876835
[TBL] [Abstract][Full Text] [Related]
9. The mechanism of inhibition and "reversal" of mitogen-induced lymphocyte activation in a model of purine-nucleoside phosphorylase deficiency.
Albert D; Bluestein HG; Willis RC; Nette K; Seegmiller JE
Cell Immunol; 1984 Jul; 86(2):501-9. PubMed ID: 6428752
[TBL] [Abstract][Full Text] [Related]
10. Establishment and characterization of adenosine deaminase-deficient human T cell lines.
Kohn DB; Mitsuya H; Ballow M; Selegue JE; Barankiewicz J; Cohen A; Gelfand E; Anderson WF; Blaese RM
J Immunol; 1989 Jun; 142(11):3971-7. PubMed ID: 2497184
[TBL] [Abstract][Full Text] [Related]
11. Adenosine deaminase impairment and ribonucleotide reductase activity and levels in HeLa cells.
Lin AL; Elford HL
J Biol Chem; 1980 Sep; 255(18):8523-8. PubMed ID: 6997299
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 2 responsive lymphocytes in patients with adenosine deaminase deficiency.
Cowan MJ; Smith W; Ammann AJ
Clin Immunol Immunopathol; 1989 Oct; 53(1):59-67. PubMed ID: 2569954
[TBL] [Abstract][Full Text] [Related]
13. Effects of deoxyadenosine on the activation of ADA inhibited T & B cells.
Webster AD; Ip H; Pereira S
Clin Exp Immunol; 1982 Dec; 50(3):587-95. PubMed ID: 6299634
[TBL] [Abstract][Full Text] [Related]
14. Purinogenic immunodeficiency diseases. Differential effects of deoxyadenosine and deoxyguanosine on DNA synthesis in human T lymphoblasts.
Wilson JM; Mitchell BS; Daddona PE; Kelley WN
J Clin Invest; 1979 Nov; 64(5):1475-84. PubMed ID: 115901
[TBL] [Abstract][Full Text] [Related]
15. Effects of deoxyadenosine on ribonucleotide reductase in adenosine deaminase-deficient lymphocytes.
Takeda E; Kuroda Y; Naito E; Yokota I; Saijo T; Hirose M; Miyao M
J Inherit Metab Dis; 1991; 14(1):87-95. PubMed ID: 1830628
[TBL] [Abstract][Full Text] [Related]
16. Deoxynucleoside overproduction in deoxyadenosine-resistant, adenosine deaminase-deficient human histiocytic lymphoma cells.
Kubota M; Carrera CJ; Wasson DB; Carson DA
Biochim Biophys Acta; 1984 May; 804(1):37-43. PubMed ID: 6372866
[TBL] [Abstract][Full Text] [Related]
17. The effect of nucleosides and deoxycoformycin on adenosine and deoxyadenosine inhibition of human lymphocyte activation.
Uberti J; Lightbody JJ; Johnson RM
J Immunol; 1979 Jul; 123(1):189-93. PubMed ID: 312874
[TBL] [Abstract][Full Text] [Related]
18. Enzyme replacement and other biochemical approaches to the therapy of adenosine deaminase deficiency.
Polmar SH
Ciba Found Symp; 1978; (68):213-30. PubMed ID: 227649
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of RNA synthesis by deoxyadenosine plus deoxycoformycin in resting lymphocytes.
Matsumoto SS; Yu J; Yu AL
J Immunol; 1983 Dec; 131(6):2762-6. PubMed ID: 6196398
[TBL] [Abstract][Full Text] [Related]
20. Effect of hydroxyurea and 5-fluorodeoxyuridine on deoxyribonucleoside triphosphate pools early in phytohemagglutinin-stimulated human lymphocytes.
Tyrsted G
Biochem Pharmacol; 1982 Oct; 31(19):3107-13. PubMed ID: 6216891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]